文献速递慢性肾脏病肾血管病与高血压

慢性肾脏病患者血压变异性与死亡及心血管结局的关系

Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-01-02

在402例CKD患者队列中,评估短期(24小时动态血压)和长期(诊室随访间)收缩压变异性与死亡或心血管事件复合终点的关联。中位随访4.8年(短期)和3.2年(长期)后,长期血压变异性与复合终点显著相关(每5 mmHg SD升高HR 1.24,95%CI 1.01-1.51),而短期血压变异性无显著关联(HR 0.92,95%CI 0.68-1.25)。两种变异性均未改善风险判别或重分类。

要点

  • 长期收缩压变异性与CKD患者死亡和心血管事件风险独立相关。
  • 短期动态血压变异性未显示与复合终点的显著关联。
  • 血压变异性对CKD风险预测的增量价值有限。

核心结论

  • 在CKD患者中,长期而非短期收缩压变异性与死亡和心血管事件风险相关。
  • 血压变异性在CKD风险预测中的作用有限。

研究设计与样本

  • 前瞻性队列研究,纳入402例CKD患者。
  • 短期血压变异性来自24小时动态血压监测,长期血压变异性来自诊室随访间测量,均以血压测量值的标准差定义。

主要发现

  • 短期收缩压变异性均值±SD为12.6±3.3 mmHg,长期为12.7±5.1 mmHg。
  • 短期血压变异性分析中,125例发生复合终点,中位随访4.8年(IQR 2.3-8.6年)。
  • 长期血压变异性分析中,110例发生复合终点,中位随访3.2年(IQR 1.0-7.5年)。
  • 调整分析中,长期血压变异性与复合终点显著相关(每5 mmHg诊室收缩压SD升高HR 1.24,95%CI 1.01-1.51)。
  • 短期收缩压变异性与复合终点无显著关联(每5 mmHg 24小时动态收缩压SD升高HR 0.92,95%CI 0.68-1.25)。

临床怎么用

  • 临床关注CKD患者长期诊室间收缩压变异性可能有助于风险评估。
  • 不宜仅凭短期动态血压变异性预测CKD患者心血管风险。

局限性

  • 样本量有限(402例),可能影响统计效能。
  • 研究未报告血压变异性对风险判别或重分类的改善,提示预测价值有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Short-term BP variability (derived from 24-hour ambulatory BP monitoring) and long-term BP variability (from clinic visit to clinic visit) are directly related to risk for cardiovascular events, but these relationships have been scarcely investigated in patients with CKD, and their prognostic value in this population is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a cohort of 402 patients with CKD, we assessed associations of short- and long-term systolic BP variability with a composite end point of death or cardiovascular event. Variability was defined as the standard deviation of observed BP measurements. We further tested the prognostic value of these parameters for risk discrimination and reclassification. RESULTS: Mean ± SD short-term systolic BP variability was 12.6±3.3 mm Hg, and mean ± SD long-term systolic BP variability was 12.7±5.1 mm Hg. For short-term BP variability, 125 participants experienced the composite end point over a median follow-up of 4.8 years (interquartile range, 2.3-8.6 years). For long-term BP variability, 110 participants experienced the composite end point over a median follow-up of 3.2 years (interquartile range, 1.0-7.5 years). In adjusted analyses, long-term BP variability was significantly associated with the composite end point (hazard ratio, 1.24; 95% confidence interval, 1.01 to 1.51 per 5-mm Hg higher SD of office systolic BP), but short-term systolic BP variability was not (hazard ratio, 0.92; 95% confidence interval, 0.68 to 1.25 per 5-mm Hg higher SD of 24-hour ambulatory systolic BP). Neither estimate of BP variability improved risk discrimination or reclassification compared with a simple risk prediction model. CONCLUSIONS: In patients with CKD, long-term but not short-term systolic BP variability is related to the risk of death and cardiovascular events. However, BP variability has a limited role for prediction in CKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Mallamaci F, Tripepi G, D'Arrigo G, et al. Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients. Clin J Am Soc Nephrol. 2019. PMID: 30602461. doi:10.2215/CJN.04030318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。